Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence

NCT03508648 is registered in ClinicalTrials.gov with GTx as lead sponsor.

NCT NCT03508648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03508648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence
Lead sponsor
GTx
Phase
Phase 2
Overall status
Withdrawn
Start date
May 28, 2018
Completion date
September 21, 2018
Enrollment
0 (actual)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

stress urinary incontinence